loader
Please Wait
Applying Filters...

Evonik Evonik

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Technical details about Crenolanib, learn more about the structure, uses, toxicity, action, side effects and more

    Client Email Product
    Menu

    Crenolanib

    INTERMEDIATES

    DIGITAL CONTENT

    PharmaCompass

    Minakem offers CDMO services for API & HPAPI, generics, regulatory expertise, track record performance & FDA & GMP certifications.

    Temad- We think of world-class quality.

    2D Structure
    1. Also known as: 670220-88-9, Crenolanib (cp-868596), Cp-868596, Aro-002, Crenolanib [usan], Cp-868,596
    Molecular Formula
    C26H29N5O2
    Molecular Weight
    443.5  g/mol
    InChI Key
    DYNHJHQFHQTFTP-UHFFFAOYSA-N
    FDA UNII
    LQF7I567TQ
    Crenolanib is an orally bioavailable benzimidazole targeting the platelet-derived growth factor receptor (PDGFR) subtypes alpha and beta and FMS-related tyrosine kinase 3 (Flt3), with potential antineoplastic activity. Upon oral administration, crenolanib binds to and inhibits both wild-type and mutated forms of PDGFR and Flt3, which may result in the inhibition of PDGFR- and Flt3-related signal transduction pathways. This results in inhibition of tumor angiogenesis and tumor cell proliferation in PDGFR and/or Flt3 overexpressing tumor cells. PDGFR and Flt3, class III receptor tyrosine kinases, are upregulated or mutated in many tumor cell types.
    1 2D Structure

    2D Structure

    2 Identification
    2.1 Computed Descriptors
    2.1.1 IUPAC Name
    1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine
    2.1.2 InChI
    InChI=1S/C26H29N5O2/c1-26(14-32-15-26)16-33-20-6-7-22-21(13-20)28-17-31(22)24-8-5-18-3-2-4-23(25(18)29-24)30-11-9-19(27)10-12-30/h2-8,13,17,19H,9-12,14-16,27H2,1H3
    2.1.3 InChI Key
    DYNHJHQFHQTFTP-UHFFFAOYSA-N
    2.1.4 Canonical SMILES
    CC1(COC1)COC2=CC3=C(C=C2)N(C=N3)C4=NC5=C(C=CC=C5N6CCC(CC6)N)C=C4
    2.2 Other Identifiers
    2.2.1 UNII
    LQF7I567TQ
    2.3 Synonyms
    2.3.1 MeSH Synonyms

    1. Cp-868,596

    2.3.2 Depositor-Supplied Synonyms

    1. 670220-88-9

    2. Crenolanib (cp-868596)

    3. Cp-868596

    4. Aro-002

    5. Crenolanib [usan]

    6. Cp-868,596

    7. Aro 002

    8. Cp 868596

    9. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo-[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine

    10. Lqf7i567tq

    11. Cp868569

    12. Crenolanib (usan)

    13. Mfcd21609260

    14. 1-[2-[5-[(3-methyloxetan-3-yl)methoxy]benzimidazol-1-yl]quinolin-8-yl]piperidin-4-amine

    15. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-benzimidazol-1-yl}quinolin-8-yl)piperidin-4-amine

    16. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1-benzimidazolyl]-8-quinolyl]-4-piperidinamine

    17. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine.

    18. 1-(2-{5-[(3-methyloxetan-3-yl)methoxy]-1h-1,3-benzodiazol-1-yl}quinolin-8-yl)piperidin-4-amine

    19. Cp-868

    20. Cp868596

    21. Crenolanib [usan:inn]

    22. Unii-lqf7i567tq

    23. Crenolanibum

    24. Cp-868596 (crenolanib)

    25. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzimidazol-1-yl)quinolin-8-yl)piperidin-4-amine

    26. 6t2

    27. Cp-868569

    28. Crenolanib [inn]

    29. Crenolanib,cp-868596

    30. [1-[2-[5-(3-methyloxetan-3-ylmethoxy)benzimidazol-1-yl]quinolin-8-yl]piperidin-4-yl]amine

    31. Crenolanib [who-dd]

    32. Mls006010956

    33. Crenolanib - Cp-868569

    34. Gtpl7882

    35. Schembl2730601

    36. Chembl2105728

    37. Dtxsid50985873

    38. Ex-a215

    39. Chebi:145365

    40. Bdbm185149

    41. Hms3656f19

    42. Bcp02384

    43. Zinc3820043

    44. Nsc763526

    45. Nsc800079

    46. S2730

    47. Akos026750597

    48. Bcp9000551

    49. Ccg-264988

    50. Cs-0566

    51. Db11832

    52. Nsc-763526

    53. Nsc-800079

    54. Sb16603

    55. Ncgc00346658-01

    56. Ncgc00346658-09

    57. 1-(2-(5-((3-methyloxetan-3-yl)methoxy)-1h-benzo[d]imidazol-1-yl)quinolin-8-yl)piperidin-4-amine

    58. Ac-32071

    59. As-57698

    60. Hy-13223

    61. Smr004702760

    62. Sy237889

    63. Ft-0665221

    64. Sw218293-2

    65. D10102

    66. J-502712

    67. Q5184160

    68. Cp-868596;cp 868596;cp868596;aro 002

    69. 1-[2-[5-[(3-methyl-3-oxetanyl)methoxy]-1h-benzimidazol-1-yl]-8-quinolinyl]-4-piperidinamine

    70. 1-{2-[5-(3-methyl-oxetan-3-ylmethoxy)-benzoimidazol-1-yl]-quinolin-8-yl}-piperidin-4-ylamine

    71. 4-piperidinamine, 1-(2-(5-((3-methyl-3-oxetanyl)methoxy)-1h-benzimidazol-1-yl)-8-quinolinyl)-

    2.4 Create Date
    2006-10-25
    3 Chemical and Physical Properties
    Molecular Weight 443.5 g/mol
    Molecular Formula C26H29N5O2
    XLogP33.7
    Hydrogen Bond Donor Count1
    Hydrogen Bond Acceptor Count6
    Rotatable Bond Count5
    Exact Mass443.23212518 g/mol
    Monoisotopic Mass443.23212518 g/mol
    Topological Polar Surface Area78.4 Ų
    Heavy Atom Count33
    Formal Charge0
    Complexity667
    Isotope Atom Count0
    Defined Atom Stereocenter Count0
    Undefined Atom Stereocenter Count0
    Defined Bond Stereocenter Count0
    Undefined Bond Stereocenter Count0
    Covalently Bonded Unit Count1
    4 Pharmacology and Biochemistry
    4.1 MeSH Pharmacological Classification

    Antineoplastic Agents

    Substances that inhibit or prevent the proliferation of NEOPLASMS. (See all compounds classified as Antineoplastic Agents.)

    Post Enquiry
    POST ENQUIRY